Seth Blackley - 02 Mar 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
02 Mar 2022
Net transactions value
-$3,563,070
Form type
4
Filing time
04 Mar 2022, 20:01:29 UTC
Previous filing
03 Mar 2022
Next filing
23 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $0 +286,867 +108% $0.000000 551,415 02 Mar 2022 Direct F1, F2
transaction EVH Class A Common Stock Tax liability $3,563,070 -129,378 -23% $27.54 422,037 03 Mar 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Leveraged Restricted Stock Unit Options Exercise $0 -286,867 -100% $0.000000* 0 02 Mar 2022 Class A Common Stock 286,867 $0.000000 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of the leveraged stock units granted to Mr. Blackley on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock.
F2 Includes restricted stock units granted under awards reported on Table I of Form 4s previously filed with the Securities and Exchange Commission.
F3 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units.
F4 Leveraged Stock Units vested on March 2, 2022.
F5 These Leveraged Stock Units do not expire.